Diamond Hill Capital Management Inc Ironwood Pharmaceuticals Inc Transaction History

Diamond Hill Capital Management Inc

  • $23.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 05, 2020
SELL
$8.58 - $14.01 $175,992 - $287,373
-20,512 Closed
0 $0
Q3 2019

Oct 30, 2019
BUY
$8.59 - $10.96 $85,900 - $109,600
10,000 Added 95.13%
20,512 $176,000
Q2 2019

Aug 01, 2019
BUY
$9.8 - $12.89 $103,017 - $135,499
10,512 New
10,512 $115,000

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Diamond Hill Capital Management Inc Portfolio

Follow Diamond Hill Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Diamond Hill Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email